BPG致力于知识的发现和传播
Home / Archive / Volume 31, Issue 28
  • 本文章
本文章的学术内容和语言评估
本文章的CrossCheck查重和Google搜索
本文章的学术规范
本文章的引用
本文章的通讯作者
本文章的研究领域
本文章的类型
本文章的开放获取政策
本文章的Google引用次数
本文章的点击和下载次数
  • 本文章浏览次数 (5041)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-4) series.
Item 
Count 
PDF61
HTML3165
Figures (1-3)440
Tables (1-4)141
 总和 = 3807
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse272
Download536
 总和 = 808
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse61
Download180
 总和 = 241
Jul 28, 2025 (publication date) through Nov 14, 2025
本文章的被引频次
本文章的期刊信息
出版物名称
World Journal of Gastroenterology
ISSN
1007-9327
本文章的出版商
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

在F6Publishing中引用其的文章
For: Han RS, Hao JW, Wang T, Xin Z, Fan GX, Wang GD, Liu MM, Liu CX, Yang QZ, Yang ZW, Lv XY, Zhang C, Bian G, Meng J, Cui ZQ, Yun XJ, Cao JH, Li SH, Fan JF, Ma HG, Gao FY, Mao T, Tian ZB, Song XH, Yu YN. Efficacy and safety of triple therapy with vonoprazan for Helicobacter pylori eradication: A multicenter, prospective, randomized controlled trial. World J Gastroenterol 2025; 31(28): 109001 [PMID: 40741473 DOI: 10.3748/wjg.v31.i28.109001]
URL: https://www.wjgnet.com/1009-3079/full/v31/i28/109001.htm
编号 Citing Articles
1
Vasily Isakov, Alexei Goncharov. Breaking barriers in the first-line <i>Helicobacter pylori</i> treatment: Chinese multicenter trial validates vonoprazan-based triple therapy. World Journal of Gastroenterology 2025; 31(40): 112312 doi: 10.3748/wjg.v31.i40.112312
写信给帮助平台
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345